Earningsreport

Q2/2019 6/30/2019 EPS -0.200 ZacksConsensus -0.050 ActVsEst (0.150) - Miss

Brooklyn ImmunoTherapeutics, Inc.  (BTX) 
NASDAQ:AMEX Investor Relations: biotimeinc.com/pexservice/investors